MÔ TẢ NỒNG ĐỘ HS TROPONIN I TRÊN BỆNH NHÂN HỘI CHỨNG CHUYỂN HÓA VÀ CÁC YẾU TỐ LIÊN QUAN

Abstract

Objective: Describe hs Troponin I concentration in patients with Metabolic Syndrome. Subjects and methods: Cross-sectional study design describes 149 metabolic syndrome cases examined at Tra Vinh Provincial General Hospital in 2023. Results: In this study, hs Troponin I levels were found to increase with age, and those aged 65 and older had significantly higher hs Troponin I levels. However, for men and women, tobacco use, alcohol use and non-use in the study, we did not find a statistically significant difference in Troponin I hs concentration. Conclusion: Based on the results of metabolic syndrome and cardiovascular diseases and cardiovascular events that have been studied previously, our research results suggest that the hs Troponin I quantitative test can be used to survey the condition of the patient. Myocardial damage without cardiovascular events in patients with metabolic syndrome and frailty over the age of 65 is both a cardiovascular risk factor in healthy people and also related to increased Troponin I hs levels.